longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Enliven Therapeutics

ELVN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Editas Medicine -16.41%, consensus target above spot

    Weekly Review·Sep 12 at 08:10 AM
    EDIT+0.37%
  • Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:49 AM
    CAI+9.61%
  • Weekly Recap | Abbvie +0.26%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:40 AM
    ABBV+0.58%
  • The Nasdaq Deep Tech Index closed down about 2.3%, underperforming the three major U.S. stock indices. Among the constituent stocks, Immuneering fell 43.22%, CorMedix fell 32.77%, Sionna Therapeutics fell 15.32%, Absci fell 14.43%, and Vanda Pharmaceuticals fell 14.05%. Xeris Pharmaceuticals rose 12.62%, Erasca rose 12.77%, Ardelyx rose 19.90%, and Enliven Therapeutics rose 50.36%

    Wallstreetcn·Jan 8 at 09:25 PM
    ERAS-0.13%ELVN+2.28%